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Introduction Peri-implantitis is an inflammatory lesion of peri-implant tissues. Eradication of the caus-
ative bacteria and decontamination of the implant surface is essential in achieving predictable and stabile 
clinical results. Photodynamic therapy (PDT) is non-invasive adjuvant therapeutic method to surgery in 
the treatment of bacterial infection.
Objective The aim of this study was to evaluate early clinical and microbiological outcomes of peri-
implantitis after surgical therapy with adjuvant PDT.
Methods Fifty-two diagnosed peri-implantitis sites were divided into two groups. PDT was used for 
decontamination of implant surface in the study group; in the control group, chlorhexidine gel (CHX) 
followed by saline irrigation was applied. Several clinical parameters were recorded before the treatment 
(baseline values) and three months after surgical treatment. Samples for microbiological identification 
were collected before therapy, during the surgical therapy (before and after decontamination of im-
plant surface), and three months thereafter, and analyzed with identification systems using biochemical 
analysis.
Results The use of PDT resulted in significant decrease of bleeding on probing in comparison to CHX 
(p < 0.001). It showed significant decontamination of implant surfaces with complete elimination of 
anaerobic bacteria immediately after surgical procedure and three months later.
Conclusion The results indicate that PDT can be used as an adjuvant therapy to surgery for decontami-
nation of implant surface and surrounding peri-implant tissues within the treatment of peri-implantitis. 
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INTRODUCTION
Peri-implantitis has been defined as an inflam-
matory process that affects the supporting mar-
ginal bone around an implant in function and 
results in bone resorption [1, 2]. It has been 
shown that the biofilm formed around osseoin-
tegrated implant has an important role in initi-
ation and progression of peri-implant diseases 
[3, 4]. Most common microorganisms that are 
related to peri-implantitis are anaerobic bacte-
ria, such as Prevotella intermedia, Porphyromo-
nas gingivalis, Aggregatibacter actinomycetem-
comitans, Bacteroides forsythia, Treponema den-
ticola, Prevotella nigrescens, Peptostreptococcus 
spp., Fusobacterium nucleatum. Some authors 
suggested that Staphylococcus aureus and Can-
dida albicans may be connected with initiation 
of peri-implantitis [3, 5]. Excessive mechani-
cal stress, residual cement, poor plaque control 
could be among risk factors in the onset and 
development of peri-implantitis [2].
Peri-implantitis is a complex disease; there-
fore, the therapy continues to be a challenge. 
Surgical therapy of peri-implantitis has been 
suggested to be superior to non-surgical ther-
apy [6]. Decontamination of implant surface is 
one of the most important and difficult steps 
because of the screw-shaped design and rough-
ness where microorganism and their products 
are incorporated. Many methods have been 
suggested, such as mechanical (dental curettes, 
ultrasonic scalers, air-powder abrasive), physical 
and/or chemical methods (citric acid, chlorhex-
idine, EDTA), usually combined with local or 
systematic antibiotics [7–12]. No single protocol 
has been suggested for solving this problem.
Photodynamic therapy (PDT) can be a new 
alternative approach for decontamination of 
implant surfaces combined with mechanical 
debridement during surgical therapy. It is a 
non-invasive therapeutic treatment of various 
infections caused by bacteria, fungi and viruses 
[13]. PDT has been defined as an oxygen-de-
pendent reaction that occurs by action of low-
energy single-frequency light (diode laser) and 
activation of the photoactive materials (pho-
tosensitizer). The photosensitizer is adminis-
tered onto exposed tissue. It binds and dyes 
cells. Upon irradiation with light of specific 
wavelength of laser, photosensitizer undergoes 
a transition from a low energy ground state to 
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an excited singlet state. Subsequently, it may decay back to 
its ground state, transition high-energy triplet state, which 
can react with biomolecules such as endogenous oxygen to 
produce very reactive products, like singlet oxygen. Singlet 
oxygen has cytotoxic effect through damage of cell mem-
brane and cell wall. Using this therapy, the target bacteria 
can be destroyed without adverse effect on the implant 
surface and surrounding peri-implant tissue [14, 15].
Some articles showed that using chlorhexidine (CHX) 
as adjunctive chemical agent to decontamination, reduced 
inflammation and microorganisms on the implant surface. 
Bioadhesive gels with higher concentrations of CHX have 
shown greater effectiveness in various clinical situations 
[16, 17]. However, ideal treatment for peri-implantitis is 
not defined yet. There are no clinical trials showing effects 
of PDT during surgical therapy of peri-implantitis.
OBjECTIvE
The aim of this study was to compare early clinical and 
microbiological effects of the adjuvant use of PDT to sur-
gical treatment of peri-implantitis, comparing the effects 
of decontamination of the implant surface to those when 
1% CHX gel was used.
METHODS
Patients were selected from two dental clinics: Department 
of Periodontology, University of Belgrade, and Department 
of Implantology, Military Medical Academy, from January 
2014 to February 2015. The research protocol was submitted 
to and approved by the Ethical Committee, University of 
Belgrade, Serbia (number 36/28). The study was carried out 
in accordance with the ethical principles of the World Medi-
cal Association Declaration of Helsinki. Before the proce-
dure, all participants were informed about the study and 
signed a written consent. All participants had to meet the 
following inclusion criteria: age >18 years, no periodontal 
or peri-implant treatment three months prior to the study, 
presence of minimum one implant in function, early or 
moderate type of peri-implantitis classified by Froum and 
Rosen [18]. Exclusion criteria were the following: uncon-
trolled medical conditions, use of systemic antibiotics in the 
previous three months, use of anti-inflammatory drugs in 
the previous six months, pregnancy and lactation, therapy 
of peri-implantitis in the last three months previously.
measurements and recording of clinical parameters
The measurements were done and recorded before any 
treatment. All measurements were made at the following 
six sites of the implant with signs of peri-implantitis: me-
siobuccal, mid-buccal, distobuccal, mesio-oral, mid-oral, 
disto-oral by one examiner (DR), using a graduated probe 
(PCPUNC 15, Hu Friedy, Chicago, IL, USA). The applied 
probing force was standardized force of 0.25 N. The im-
plant shoulder was used as landmark for calculation of 
mucosal recession and clinical attachment level. The fol-
lowing clinical parameters were registered: 
•  Peri-implant probing depth (PPD) – measured in mil-
limeters from the mucosal margin to the bottom of 
the peri-implant pocket;
•  Clinical attachment level (CAL) – measured in mil-
limeters from the implant shoulder to the bottom of 
the peri-implant pocket;
•  Mucosal recession (MR) – calculated as the difference 
between the CAL and PPD;
•  Bleeding on probing (BOP) – evaluated as being pres-
ent if bleeding was evident within 30 seconds after 
probing, or absent, if no bleeding was observed;
•  Suppuration (SUP) – present or absent.
Clinical parameters were measured and recorded be-
fore (baseline values) and three months after therapy. All 
clinical examinations were performed after removal of 
the abutments attached to the implants. Fifteen days after 
therapy the provisional restoration was performed on the 
treated implants.
microbiological samples and analysis 
The first samples for microbiological analysis were taken 
before any measurements from the deepest peri-implant 
pockets. After the removal of subgingival plaque, sample 
sites were isolated with cotton rolls and gently air dried to 
avoid contamination with saliva. Fine sterile paper points 
were inserted into the peri-implant pocket until mild re-
sistance and left in place for 30 seconds. The paper points 
were immediately transferred to the substrate used as mul-
tipurpose transport system (ESWAB LQ Amies, COPAN 
Diagnostics Inc., Murrieta, CA, USA). 
The second and third samples were taken separately 
during the surgical therapy from the implant surfaces. Af-
ter opening the flap and removing granulation tissue, the 
second sample was obtained from the implant surface by 
a transport swab. The swab was immediately transferred 
to the substrate used as multipurpose transport system 
(ESWAB LQ Amies, COPAN Diagnostics Inc.). After 
decontamination using chemical/PDT therapy, the third 
swab was taken from the implant surface applying the 
aforementioned procedure.
The samples were inoculated by standard procedures 
for the diagnosis of anaerobic bacteria. Each sample was 
inoculated on two blood agars (Columbia agar). One blood 
agar was incubated at 36.5°C for the diagnosis of aerobic 
pathogens; the other was incubated at the same tempera-
ture in a container for anaerobic diagnostics. Anaerobic 
conditions in the container were provided by generation 
bags for anaerobic conditions GENbox anaer (bioMérieux, 
Marcy l’Etoile, France). Cultivated and isolated anaerobic 
strains underwent identification process. Identification of 
isolated strains was reaffirmed by automatic systems of 
two different manufacturers: BBL Crystal ID Kit for anaer-
obes (Becton Dickinson, Sparks Glencoe, MD, USA), and 
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treatment procedure
After clinical parameters were recorded and samples 
were taken, all the patients underwent a single episode of 
non-surgical therapy. It implied mechanical method for 
debridement of implants and remaining dentition in or-
der to reduce signs of inflammation. Instructions for oral 
hygiene were proposed during the same visit. 
 
Surgical treatment
During the surgical procedure, all the patients were ran-
domly divided into two groups: the study group (PDT 
group) and the control group (CHX group). Similar meth-
odology procedure was described in a study by De Waal 
et al. [17].
Surgical treatment of peri-implantitis was performed by 
one experienced oral surgeon (ZL) two weeks after non-
surgical therapy (in accordance with Schwarz et al. [19]). 
Mucoperiosteal buccal and lingual incisions were made 
with surgical blade No. 15 under local anesthesia (2% li-
docaine with epinephrine, 1:100,000). Flaps were designed 
to permit optimal access to the peri-implant bone defect 
for granulation tissue removal and decontamination of 
the implant surface. Full thickness mucoperiosteal flaps 
were elevated buccally and lingually. Removal of granula-
tion tissue and mechanical implant surface cleaning were 
done using graphite curettes (Straumann® Dental Implant 
System; Straumann AG, Basel, Switzerland).
Decontamination of implant surfaces
In the study group, after careful removal of granulation 
tissue and mechanical debridement of implant surface, 
decontamination of implant surfaces and peri-implant tis-
sues was performed using PDT (HELBO, Photodynamic 
Systems GmbH, Wels, Austria). Photosensitizer, pheno-
thiazine chloride (HELBO® Blue Photosensitizer, bredent 
medical GmbH & Co. KG), was applied onto implant 
surface, bone and peri-implant soft tissue, for 3 minutes. 
Irrigation of photosensitizer was performed with saline, 
according to instructions of the manufacturer. Implant 
surface and the surrounding tissue were exposed to the 
laser light by means of fibers (HELBO® TheraLite Laser 
HELBO® 2D Spot Probe; Bredent medical GmbH & Co. 
KG) for 30 seconds/spot, which operates on wave length 
of 660 nm and irradiance of 100 mW (Figure 1a–f).
In the control group, after removal of granulation tis-
sue, 1% gel of chlorhexidine (Chlorhexamed® – Direkt; 
GlaxoSmithKline, GmbH & Co. KG, München, Germany) 
was put on implant surface. One minute after exposing 
implant surface with CHX, it was irrigated for 1 minute 
by saline.
Bone augmentation and bio-resorbable membrane 
were applied in peri-implant defects using artificial bone 
of bovine origin (Bio-Oss and Bio-Gide; Geistlich Pharma, 
Wolhusen, Switzerland). The mucoperiosteal flaps were 
repositioned and sutured [17, 19].
All the patients from both groups were prescribed an-
tibiotics over a five-day period (amoxicillin caps. 500 mg, 
a b c
d e f
Figure 1. Surgery procedure using PDT for decontamination implant surface: a) peri-implantitis around the implant in function; b) peri-implant 
defect; c) application of photosensitizer (HELBO® Blue); d) activation of photosensitizer by using diode laser; e) application of bovine bone graft 
and resorbable membrane; f ) result three months after the treatment
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three per day). It was recommended that patients don’t use 
mouthwash during the postoperative period.
Followed up period 
Three months after therapy samples for microbiological 
analysis were taken from the reduced peri-implant pockets 
in the same way described above. In addition, measure-
ments of clinical parameters were recorded as well. 
Statistical analysis
Data are presented as mean ± standard deviation or n (%) 
depending on data type. Chi-squared test, Mann–Whitney 
U-test, and Student’s t-test were used to assess the differences 
between the groups. Cochran’s Q-test and Wilcoxon signed-
rank test were used to assess significant differences within 
the groups. All analyses were performed in SPSS Statistics 
for Windows 20.0 (IBM Corp., Armonk, NY, USA). All p-
values less than 0.05 were considered statistically significant.
RESULTS
There were 52 peri-implantitis sites diagnosed in 40 sys-
temically healthy patients, which were treated and re-ex-
amined in a three-month period. Demography and clinical 
description of the study population are shown in Table 1. 
No adverse events and side effects were reported during 
and after therapy.
Clinical parameters and outcomes
From a total of 52 treated peri-implantitis sites, 12 peri-
implantitis sites belonged to the category of moderate, and 
31 to the category of early peri-implantitis, classified by 
Froum and Rosen [18]. The rest of peri-implantitis in-
stances had depths of ≥ 5 mm in only one peri-implant 
pocket, as one of the inclusion criteria.
The mean value and standard deviation of PPD and 
CAL are shown in Table 2. Both groups showed statis-
tically significant reduction of peri-implant pockets 
(p < 0.001). It has been shown that the greater (but not 
statistically significant) reduction of PPD was in the study 
group compared to the controls (p = 0.07). The results of 
our study showed that there was no statistically significant 
difference in CAL between the two tested groups three 
months after the therapy (p = 0.883). Also, there were no 
statistically significant differences in marginal recession.
In the study group, there was a statistically significant 
reduction of BOP at all six points compared with the 
control group three months after the therapy (p < 0.001). 
Changes in percentage of BOP are shown in Table 2. PDT 
has shown statistically significant reduction of suppuration 
compared to CHX treatment (p < 0.002).
microbiological outcomes
All cultivated anaerobic microorganisms which were 
isolated from deepest peri-implant pockets and implant 
surfaces are shown in Table 3. It was shown that some of 
these bacteria were isolated only from implant surfaces. 
Table 1. Demographic and clinical description of the study population
Characteristics Study group Control group p-value
Number of subjects 21 (52.5%) 19 (47.5%)
Gender Male 12 (57.14%) 12 (63.15%) 0.703
Mean age (years) (mean ±SD) 57.59 60.00 0.408
Mean time (years) after implant placement (mean ±SD) 7.68 ± 3.76 6.21 ± 3.064 0.236
Subjects with a history of treated periodontitis; n (%) 8 (29.6%) 10 (40%) 0.432
Localization of implants, n (%)
Maxilla 8 (29.6%) 6 (24)
0.647
Mandible 19 (70.4%) 19 (76%)
Type of restoration, n (%)
Cement retained fixed partial denature 13 (46.4%) 19 (79.2%)
0.010a
Screw retained fixed partial denture 6 (21.4%) 2 (8.3%)
Cement retained single crown 4 (14.3%) 3 (12.5%)
Overdenture on implants 5 (17.9%) 0 (0)
a Significant statistical difference in type of prosthetic restauration among the groups at baseline by Pearson’s χ2 test (p < 0.01)
SD – standard deviation 
No significant differences were observed among the groups at baseline by Pearson’s χ2 or Independent Samples Test (T-test).
Table 2. Mean pocket probing depth (PPD) ±SD, mean clinical attachment level (CAL) ±SD, mean number of marginal recession (%), mean 
bleeding on probing (BOP) – positive sites (%) at each implant at baseline and three months later
Parameter
Baseline 3 months
PDT CHX PDT CHX
Peri-implant PPD (mm) 5.74 ± 1.55a 4.48 ± 1.08b 3.26 ± 0.79a 2.86 ± 0.755b
CAL (mm) 5.32 ± 1.36a 4.63 ± 1.28b 3.35 ± 1.67a 3.16 ± 1.25b
BOP 28 (100%) 24 (100%) 5 (17.9%)c 12 (50%)c
a Significant statistical difference measured before and three months after PDT by T-test (p < 0.001);
b Significant statistical difference measured before and three months after CHX by T-test (p < 0.001);
c Significant statistical difference between the groups by Pearson’s χ2 test (p < 0. 001)





Candida spp. was also isolated from the deepest peri-
implant pockets.
The results showed that the amount of anaerobic mi-
croorganisms was significantly reduced and in most cases 
eliminated, after using both anti-infection therapeutic 
methods during surgery therapy as well as three months 
after the therapy procedure. It showed significant reduc-
tion of anaerobic microorganisms in the study group in 
comparison with the control group, immediately after 
decontamination of the implant surface and also three 
months after (Veillonella spp., p < 0.010; Staphylococcus 
aureus, p < 0.002; Peptostreptococcus spp., p < 0.002; Pep-
tostreptococcus asaccharolyticus, p < 0.035; Actinomyces 
naeslundii, p < 0.014; Prevotella intermedia, p < 0.011; 
Porphyromonas gingivalis, p < 0.001; Actinomyces mey-
eri, p < 0.007). Three months after therapy, Actinomyces 
naeslundii was only isolated in peri-implant pockets in the 
control group.
The results of the study show that using chlorhexidine 
leads to significant reduction of Actinomyces odontolyticus 
(p < 0.046), Fusobacterium nucleatum (p = 0.23) compared 
with using photodynamic therapy. The presence of Ag-
gregatibacter actinomycetemcomitans, Tannerella forsythia, 
and Treponema denticola was not identified.
DISCUSSION
The short-term results of the present study show that both 
examined methods for debridement and decontamination 
of implant surfaces during surgical therapy (PDT and 1% 
chlorhexidine gel), significantly improve clinical and mi-
crobiological outcomes.
In the current literature, most attention is given to sys-
temic and/or local use of antibiotics or implantoplasty for 
the decontamination of implant surfaces during surgical 
procedures [3, 10, 20]. However, these methods showed 
side effects, as well as bacterial resistance to some drugs 
and allergic reactions during and after their consumption 
[10]. It has been recorded that implantoplasty leads to 
marginal recession, which is disadvantageous in terms of 
function and aesthetics [2, 20].
Some authors consider PDT to be less harmful and ef-
fective solution for the decontamination of the implant 
surface [13, 14]. This therapy was widely used in non-
surgical therapy of peri-implantitis [15, 21, 22]. It has been 
suggested that using only photodynamic therapy several 
times may lead to total recovery [22]. Schwarz et al. [6] 
suggested that surgical therapy of peri-implantitis has been 
superior to non-surgical therapy. The explanation lies in 
the open access and controlled removal of granulation tis-
sue and decontamination of the exposed implant surfaces.
The results of the present study show that there are 
statistically significant changes in peri-implant probing 
depth and clinical attachment level measured at baseline 
and three months after therapy. The depth of peri-implant 
pockets in both tested groups was reduced approximately 
2 mm. Higher reduction of peri-implant pocket depth was 
in the study group, but without statistical significance. This 
could be explained by larger baseline levels of peri-im-
plant pockets depth recorded in the study group. It seems 
that PDT can promote re-osseointegration more rapidly 
than CHX, without side effects on the bone. The results 
show significant reduction of BOP and suppuration three 
months after using PDT. It is known that BOP is one of 
the most essential and important signs of peri-implantitis; 
therefore, the use of PDT can achieve elimination of BOP 
and promote better healing. In the study by De Waal et 
al. [17], similar methodology was used, but they didn’t 
achieve the significant difference in clinical parameters 
using two concentration of chlorhexidine solutions (0.12% 
and 2%) in the examined follow-up periods. These results 
differ from ours due to improvements of clinical parame-
ters in our study. In the study by Heitz-Mayfield et al. [10], 
after surgical debridement and implant surface decontami-
nation following by saline irrigation, systemic amoxicillin 
Table 3. Number (n) of culture-positive implants at baseline and culture-negative after decontamination of selected anaerobes; mean number 
(%) of total anaerobic bacteria load on culture-positive implants; before any treatment (Tpre); before decontamination – during surgical therapy 
(Spre); after decontamination – during surgical therapy (Spost); three months later (Tpost )
Anaerobes
Experimental group (PDT, n = 27) Control group (1% CHX gel, n = 25)
Tpre Spre Spost Tpost Tpre Spre Spost Tpost
Porphyromonas gingivalis 4 (14.3) 8 (28.6) 0 (0) 0 (0) ¥ 4 (16.7) 2 (8.3 ) 0 (0) 0 (0)
Prevotella intermedia 5 (17.9) 6 (21.4) 0 (0) 0 (0) ¥ 1 (4.2) 3 (12.5) 0 (0) 0 (0)
Peptostreptococcus spp. 5 (17.9)* 3 (10.7) 0 (0) 0 (0) ¥ 0 (0) 5 (20.8) 0 (0) 0 (0) ¥
Fusobacterium nucleatum 1 (3.6) 4 (14.3) 0 (0) 0 (0) ¥ 2 (8.3) 5 (20.8) 0 (0) 0 (0) ¥
Peptostreptococcus asaccharolyticus 4 (14.3) 1 (3.6) 0 (0) 0 (0) ¥ 2 (8.3) 0 (0) 0 (0) 0 (0)
Actinomyces naeslundii 2 (7.1) 8 (28.6) 0 (0) 3 (10.7)¥ 4 (16.7) 6 (25) 0 (0) 2 (8.3)
Veillonella spp. 9 (32.1) 9 (32.1) 2 (7.1)* 2 (7.1) ¥ 3 (12.7) 9 (37.5) 7 (29.2)* 3 (12.5) ¥
Staphylococcus aureus 0 (0) 3 (10.7) 0 (0) 0 (0) ¥ 0 (0) 5 (20.8) 0 (0) 0 (0) ¥
Staphylococcus saccharolyticus 0 (0) 2 (7.1) 0 (0) 0 (0) 0 (0) 2 (8.3) 0 (0) 0 (0)
Actinomyces meyeri 0 (0) 4 (14.3) 0 (0) 0 (0) ¥ 2 (8.3) 0 (0) 0 (0) 0 (0)
Actinomyces odontolyticus 1 (3.6 ) 0 (0) 0 (0) 3 (10.7) 4 (16.7) 0 (0) 0 (0) 4 (16.7)¥
N = 52; 
* Statistically significant change from baseline to three months after therapy, as well as before and after decontamination of implant surface between the two 
groups according to Pearson’s χ2 test, p < 0.05;
¥ Statistically significant change from baseline to three months after therapy, as well as before and after decontamination of implant surface during surgical 
procedure within the two tested groups according to Cochran’s Q-test, p < 0.05
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and metronidazole were prescribed. Although clinical re-
sults of their study were similar to ours, using adjunctive 
PDT could be efficient, as it leads to lower consumption 
of antibiotics and antiseptics, without side effects.
Cultivation of anaerobic microorganisms showed the 
presence of various anaerobes isolated from peri-implant 
pocket before any treatment, as well as on implant surface 
before decontamination. Most of these bacteria belonged 
to the pathogenic microorganisms from red and orange 
complex described by Socransky et al. [23]. In our study, 
bacteria of yellow, purple, and green complex were also 
found, which is assumed to be the first phase of coloniza-
tion of implant surface. This can also represent a possible 
bridge for the adherence of bacteria from orange and red 
complexes in a later phase of colonization and maturation 
of dental biofilm. The results also showed the presence of 
Staphylococcus aureus. It was mentioned that it can be one 
of the possible pathogenic microorganisms that promote 
initiation and progression of peri-implantitis. This bacte-
ria was isolated only from the implant surface, so it can 
be assumed that this can be a very virulent strain, which 
can enable the progression of peri-implantitis [24]. The 
presence of Candida albicans could be due to inappropri-
ate oral hygiene. Therefore, Candida couldn’t have had an 
influence on initiation of peri-implantitis, as mentioned 
in some early papers [2].
In both examined groups, statistically significant reduc-
tion of anaerobic microorganisms from the peri-implant 
pockets was evident in the follow-up period and also from 
implant surface immediately after decontamination. The 
results show that application of PDT significantly reduced 
the amount of bacteria, especially those from the red and 
orange complex. De Waal et al. [17] achieved reduction 
of microorganisms from implant surface between groups 
during a surgical procedure, but results were not as statisti-
cally significant as in our study. Our study showed signifi-
cant reduction of microorganisms after using both anti-
infection therapeutic methods of decontamination during 
surgical therapy. In vitro study of Marotti et al. [14] showed 
significant reduction of anaerobic microorganisms after 
application of PDT and 0.12% solution of chlorhexidine 
on anodized implants, which are results similar to ours. 
Another study  showed that using PDT with toluidine blue 
as a dye can reduce but not eliminate pathogenic micro-
organisms from implant surfaces (Prevotella intermedia, 
Porphyromonas gingivalis) [15]. Presence of these bacteria 
is one of the most important factors in peri-implantitis 
progression. In contrast, our study has shown elimination 
of these bacteria. The reason for these differences could be 
the composition of photosensitizer. Phenothiazine chlo-
ride might have greater ability to bind different microor-
ganisms compared to toluidine blue.
In the control group, chlorhexidine gel was chosen for 
decontamination because of its widely spread use as an 
antiseptic in different therapeutic procedures. It might be 
capable of adhering to implant surface. The results show 
statistically significant reduction of Fusobacterium nuclea-
tum and Actinomyces odontolyticus after using 1% of CHX 
in adhesive gel, which can be explained by high concen-
tration and viscosity of CHX in the gel. Although earlier 
studies described that CHX has a bactericidal effect on mi-
croorganisms regardless of the concentration [17], it seems 
that CHX cannot remove dental biofilm, which can lead to 
renewed adherence of microorganism and reappearance of 
inflammation. Similarly, in the control group, the results of 
the present study showed the reduction of BOP, as one of 
the signs of inflammation, of only 50%, which confirmed 
the earlier assumption.
CONCLUSION
Even with limitations of the present study, such as short 
observation period, it can be concluded that photody-
namic therapy achieves significant reduction of micro-
organisms from implant surface and peri-implant tissue 
when compared with chlorhexidine application, without 
adverse and side effects on implants and surrounding tis-
sue. Therefore, PDT could be suggested as a new strategy 
for decontamination of implant surface during surgical 
treatment of peri-implantitis.
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КРАТАК САДРжАЈ
Увод Периимплантитис је инфламаторни процес који зах-
вата мека ткива и потпорну кост око осеоинтегрисаног 
имплантата. Елиминација патогених микроорганизама и 
деконтаминација имплантне површине представљу нај-
битнији корак у постизању стабилних клиничких резултата. 
Фотодинамска терапија (ФДТ) представља додатни неинва-
зивни метод у терапији бактеријских инфекција.
Циљ рада Циљ рада била је процена клиничких и микро-
биолошких параметара након хируршке терапије периим-
плантитиса уз додатну примену ФДТ.
Методе рада Сва дијагностикована места периимплан-
титиса (n = 52) била су подељена у две групе: у студијској 
групи, за деконтаминацију имплантне површине током 
хируршке процедуре коришћена је ФДТ; у контролној гру-
пи, за деконтаминацију имплантне површине коришћен је 
хлорхексидин у гелу (CHX). Клинички параметри праћени 
су пре терапијске процедуре и три месеца после терапије. 
Узорци за микробиолошку анализу узимани су пре и три 
месеца после терапије, као и током хируршке процедуре, 
пре и после деконтаминације имплантне површине. За 
идентификацију изолованих анаероба коришћен је систем 
који ради по принципу биохемијске анализе изолованих 
микробиолошких сојева.
Резултати Резултати студије су показали да применом ФДТ 
долази до знатне редукције крварења на провокацију у 
поређењу са применом CHX (p < 0,001). Примена ФДТ, као 
помоћног терапијског средства, омогућава потпуну елими-
нацију анаеробних бактерија са имплантне површине.
Закључак Резултати показују да ФДТ може да се користи 
као помоћно терапијско средство за деконтаминацију им-
плантне површине и периимплантног ткива у оквиру тера-
пије периимплантитиса.
Кључне речи: периимплантитис; деконтаминација; фото-
динамска терапија
Процена ефикасности фотодинамске терапије у терапији периимплантитиса 
после три месеца: рандомизирана контролисана клиничка студија
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